The Promise and Challenge of Big Data for Pharma
Harvard Business Review
NOVEMBER 29, 2016
It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. It also allows companies to assess real-world challenges that cannot be observed in a clinical trial, such as drug compliance and the utilization of health care resources.
8 
Let's personalize your content